Wellington Management Group LLP lowered its stake in shares of MetLife, Inc. (NYSE:MET – Free Report) by 14.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,548,364 shares of the financial services provider’s stock after selling 3,106,583 shares during the period. Wellington Management Group LLP’s holdings in MetLife were worth $1,529,869,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently bought and sold shares of the company. MeadowBrook Investment Advisors LLC lifted its holdings in shares of MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. raised its stake in MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 186 shares during the last quarter. Wolff Wiese Magana LLC raised its stake in MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 277 shares during the last quarter. Peterson Financial Group Inc. acquired a new stake in MetLife during the 3rd quarter worth about $30,000. Finally, Fortitude Family Office LLC grew its position in MetLife by 177.3% during the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 266 shares during the period. Hedge funds and other institutional investors own 89.81% of the company’s stock.
MetLife Trading Up 0.6 %
MET stock opened at $85.88 on Friday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. MetLife, Inc. has a 12-month low of $63.19 and a 12-month high of $89.05. The stock has a market cap of $59.47 billion, a price-to-earnings ratio of 17.31, a PEG ratio of 0.79 and a beta of 1.06. The business’s 50-day moving average is $83.73 and its 200 day moving average is $76.91.
MetLife Announces Dividend
Analysts Set New Price Targets
MET has been the topic of several analyst reports. Piper Sandler increased their price target on MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Wells Fargo & Company increased their price target on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. TD Cowen increased their price target on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research report on Wednesday, November 27th. StockNews.com raised MetLife from a “hold” rating to a “buy” rating in a research report on Monday, November 25th. Finally, Barclays cut their price target on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Thursday, October 31st. Fourteen research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $88.62.
View Our Latest Stock Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- How to Invest in Blue Chip Stocks
- AeroVironment Dives Into a Buying Opportunity
- How to invest in marijuana stocks in 7 steps
- Ulta Stock Rally: Is There Still Room for More Upside?
- ETF Screener: Uses and Step-by-Step Guide
- Buy the Dip? Chewy Stock’s Growth Story Is Far From Over
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.